Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 31.76%223.84B | 174.84%169.88B | 360.03%61.81B | -121.29%-23.77B | -34.72%111.65B | 10.20%171.04B | 1.97%155.21B | 4.75%152.2B | -2.89%145.3B | -3.50%149.64B |
Net profit before non-cash adjustment | 48.18%166.01B | 857.59%112.03B | 117.25%11.7B | -176.07%-67.8B | -31.14%89.13B | 14.55%129.44B | -1.41%113B | 5.02%114.61B | -1.22%109.14B | -1.94%110.49B |
Total adjustment of non-cash items | 12.26%65.63B | 61.25%58.46B | -33.40%36.25B | 98.06%54.44B | -30.65%27.49B | -6.98%39.64B | 37.02%42.61B | -25.09%31.1B | 0.47%41.52B | -3.99%41.32B |
-Depreciation and amortization | 0.81%46.7B | 5.04%46.33B | -3.91%44.1B | 16.36%45.9B | 3.23%39.45B | 1.67%38.21B | -2.44%37.59B | 6.34%38.53B | 3.86%36.23B | -6.18%34.88B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --5.63B | ---- | ---- | ---- | ---- | ---- | ---- |
-Share of associates | -303.33%-183M | -81.25%90M | -1.03%480M | 165.03%485M | -47.56%183M | 420.18%349M | 27.33%-109M | -2.04%-150M | -11.36%-147M | -17.86%-132M |
-Disposal profit | --0 | 44.29%-239M | ---429M | --0 | -47.83%-1.26B | 61.92%-853M | -125.81%-2.24B | 11.74%-992M | -23.38%-1.12B | -4.23%-911M |
-Net exchange gains and losses | ---- | ---- | --0 | --0 | -85.71%2M | 200.00%14M | -153.85%-14M | 273.33%26M | -134.09%-15M | 266.67%44M |
-Other non-cash items | 55.59%19.11B | 255.42%12.28B | -426.35%-7.9B | 122.24%2.42B | -669.30%-10.89B | -74.12%1.91B | 217.05%7.39B | -196.01%-6.31B | -11.63%6.57B | 8.84%7.44B |
Changes in working capital | -1,179.97%-7.8B | -104.39%-609M | 233.18%13.86B | -109.44%-10.41B | -353.21%-4.97B | 590.50%1.96B | -106.16%-400M | 221.38%6.49B | -145.73%-5.35B | -232.21%-2.18B |
-Change in receivables | -3.89%-6.78B | -207.88%-6.52B | 57.69%-2.12B | -133.97%-5.01B | 790.82%14.74B | -89.52%-2.13B | -116.39%-1.13B | 786.11%6.87B | 73.30%-1B | -164.95%-3.75B |
-Change in inventory | 143.58%3.51B | -250.23%-8.06B | 472.17%5.36B | 47.87%-1.44B | -525.89%-2.76B | 187.35%649M | -450.37%-743M | -165.85%-135M | 107.50%205M | -632.44%-2.73B |
-Change in payables | -137.93%-5.11B | 32.91%13.47B | 377.41%10.13B | 77.36%-3.65B | -522.97%-16.13B | 252.82%3.81B | 273.52%1.08B | 88.11%-623M | -229.33%-5.24B | 23.63%4.05B |
-Provision for loans, leases and other losses | 14.20%579M | 5.19%507M | 258.55%482M | 62.65%-304M | -121.80%-814M | -194.59%-367M | 2.11%388M | -44.69%380M | 169.41%687M | 111.90%255M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 1.38%-357M | 20.44%-362M | -31.12%-455M | -19.24%-347M | -41.26%-291M | 0.48%-206M | 1.43%-207M | 3.23%-210M | 62.78%-217M | 37.11%-583M |
Interest received (cash flow from operating activities) | 24.92%787M | 0.16%630M | -6.40%629M | -32.19%672M | 9.14%991M | -6.00%908M | -22.16%966M | 7.17%1.24B | 33.10%1.16B | -11.41%870M |
Tax refund paid | -1,000.12%-26.59B | 67.26%-2.42B | -1,797.94%-7.38B | 99.00%-389M | -6.11%-39.02B | -11.07%-36.77B | 7.07%-33.1B | -0.82%-35.62B | 20.44%-35.33B | -28.95%-44.41B |
Other operating cash inflow (outflow) | 0.00%-1M | -200.00%-1M | 1M | 0 | 0.00%-1M | 0.00%-1M | -1M | 0 | -1M | 0 |
Operating cash flow | 17.85%197.67B | 207.18%167.73B | 329.09%54.6B | -132.50%-23.83B | -45.67%73.34B | 9.86%134.97B | 4.46%122.86B | 6.04%117.61B | 5.12%110.91B | -12.56%105.51B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 45.40%-48.33B | 10.44%-88.52B | 11.44%-98.84B | 12.10%-111.61B | -61.60%-126.97B | -42.55%-78.57B | -14.36%-55.12B | -42.52%-48.2B | -20.93%-33.82B | -50.56%-27.97B |
Net intangibles purchase and sale | 6.87%-4.37B | 26.32%-4.69B | -19.11%-6.36B | 27.40%-5.34B | -39.44%-7.36B | -98.01%-5.28B | -26.48%-2.67B | 41.18%-2.11B | ---3.58B | ---- |
Net investment product transactions | 162.18%31.71B | -33.60%-51B | 12.15%-38.17B | -127.79%-43.45B | 421.14%156.36B | -465.61%-48.69B | -24.78%13.32B | 121.85%17.7B | -126.96%-81.02B | -1,693.87%-35.7B |
Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 50.00%-1M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 311.76%350M |
Net changes in other investments | -28.96%-285M | -105.03%-221M | 1,406.55%4.39B | 77.45%-336M | 47.18%-1.49B | -452.05%-2.82B | 50.34%-511M | -209.94%-1.03B | 93.06%-332M | -66.49%-4.79B |
Investing cash flow | 85.28%-21.27B | -3.92%-144.43B | 13.53%-138.98B | -882.79%-160.74B | 115.17%20.53B | -200.93%-135.36B | -33.75%-44.98B | 71.68%-33.63B | -74.38%-118.75B | -191.57%-68.1B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -1,803.09%-32.01B | -102.99%-1.68B | -43.11%56.24B | 562.97%98.86B | -143.85%-21.35B | 5,023.56%48.69B | -128.45%-989M | 578.13%3.48B | 2.94%-727M | 98.90%-749M |
Net common stock issuance | 13.21%1.78B | 30.92%1.58B | -8.38%1.2B | 106.76%1.31B | -1,958.13%-19.44B | 105.47%1.05B | 7.39%-19.12B | -3,553.01%-20.65B | --598M | --0 |
Cash dividends paid | -42.11%-15.36B | -27.00%-10.81B | 25.60%-8.51B | 20.80%-11.44B | -9.97%-14.44B | 0.30%-13.13B | -13.45%-13.17B | 0.47%-11.61B | -7.58%-11.67B | -8.54%-10.84B |
Net other fund-raising expenses | -60.87%-37M | -1,050.00%-23M | 84.62%-2M | 43.48%-13M | -360.00%-23M | 91.67%-5M | -1,400.00%-60M | 78.95%-4M | -103.91%-19M | 7.05%486M |
Financing cash flow | -317.09%-45.63B | -122.36%-10.94B | -44.85%48.93B | 260.57%88.72B | -250.97%-55.26B | 209.76%36.6B | -15.83%-33.35B | -143.68%-28.79B | -6.37%-11.81B | 85.74%-11.11B |
Net cash flow | ||||||||||
Beginning cash position | 9.52%142.23B | -21.44%129.87B | -36.70%165.32B | 17.35%261.16B | 19.43%222.55B | 31.42%186.35B | 63.67%141.8B | -18.48%86.64B | 32.82%106.28B | 32.08%80.02B |
Current changes in cash | 957.78%130.78B | 134.88%12.36B | 63.02%-35.45B | -348.23%-95.85B | 6.62%38.61B | -18.68%36.22B | -19.31%44.53B | 380.76%55.19B | -174.73%-19.66B | 35.25%26.31B |
Effect of exchange rate changes | ---- | ---- | --0 | --0 | --0 | -200.00%-14M | 153.85%14M | -273.33%-26M | 134.09%15M | -214.29%-44M |
Cash adjustments other than cash changes | ---- | ---- | ---- | --1M | ---- | ---- | 200.00%1M | ---1M | ---- | ---- |
End cash Position | 91.95%273.02B | 9.52%142.23B | -21.44%129.87B | -36.70%165.32B | 17.35%261.16B | 19.43%222.55B | 31.42%186.35B | 63.67%141.8B | -18.48%86.64B | 32.82%106.28B |
Free cash flow | 94.54%144.98B | 247.28%74.52B | 64.06%-50.6B | -130.81%-140.78B | -219.31%-61B | -21.44%51.12B | -3.32%65.07B | -8.41%67.31B | -5.22%73.49B | -24.04%77.54B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |